iFuse Bedrock Granite Implant System: Surgical procedure of the spine with pelvic fixation/fusion using iFuse Bedrock Granite
Study summary
PAULA aims to collect data on the safety, performance, and effectiveness of iFuse Bedrock Granite (GRANITE) in patients who have spinal fusion surgery with pelvic fixation/ fusion.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. ≥ 18 years of age at screening.
2. Patient is scheduled for spinal fusion with pelvic fixation/fusion using iFuse Bedrock Granite
3. Patient is willing and able to provide written informed consent
Exclusion Criteria:
1. Any known anatomic issues or permanent implants already in the pelvis that could interfere with placement of the study device(s)
2. Prominent neurologic or uncontrolled psychiatric condition that would interfere with study participation
3. Known allergy to titanium or titanium alloys
4. Current local or systemic infection that raises the risk of surgery
5. Currently pregnant or planning pregnancy in the next 2 years
6. Known or suspected active drug or alcohol abuse, including opioids
7. Patient is a prisoner or ward of the state
8. Patient is enrolled in an investigational clinical trial related to the spine
Primary outcome measure(s)
Postoperative incidence of serious adverse events probably or definitely related to GRANITE — 2 years
Postoperative incidence of SI joint pain in subject without SI joint pain at baseline — 2 years
Postoperative incidence of L5-S1 pseudoarthrosis — 2 years
Postoperative incidence of pelvic construct failure — 2 years Failure is defined as:
* Breakage of any implants placed into sacrum or ilium
* Rod breakage in the lumbosacral region
* Pelvic implant loosening that either causes new or worsened pain or requires surgical adjustment/revision
Postoperative incidence of device failures related to GRANITE (e.g., rod disengagement, screw pullout) — 2 years
Radiographic — 12 month and 24 months Bony apposition to the implant at 12 and 24 months as assessed by CT scan
Change in Quality of Life PROs — 6 month, 12 month and 24 months Scores on PROs at follow up timepoints compared to baseline
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.